Use of chemotherapy and loco‐regional therapy in stage IA triple‐negative breast cancer and their association with oncologic outcomes: A cancer registry study

Documenti analoghi

• Adding carboplatin to adjuvant chemotherapy improved survival in early‐stage triple‐negative breast cancer
  di: Leah Lawrence
  Pubblicazione: (2026)
• Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors
  di: Tomomi Nishimura, et al.
  Pubblicazione: (2024)
• Exploration of the sensitization effect of Chaihu Shugan powder on chemotherapy for triple‐negative breast cancer and its active ingredients
  di: Wei Wei, et al.
  Pubblicazione: (2024)
• Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers.
  di: Cogoluegnes, Sarah, et al.
  Pubblicazione: (2026)
• Receipt of guideline‐concordant local and chemotherapy‐based systemic therapy for patients with triple‐negative breast cancer: 10‐year survival outcomes in a multi‐state population‐based analysis
  di: Joseph Lipscomb, et al.
  Pubblicazione: (2026)